Zydus Lifescience Gets CDSCO Panel Nod to Study Aflibercept
New Delhi: The drug major Zydus Lifescience has got the green signal from the Subject Expert Committee SEC functional under ...
New Delhi: The drug major Zydus Lifescience has got the green signal from the Subject Expert Committee SEC functional under ...
New Delhi: The drug major Alkem Laboratories has got the green signal from the Subject Expert Committee (SEC) functional under ...
New Delhi: In line with the proposal to conduct a pivotal clinical investigation of the proposed product Nerivio, the Subject ...
New Delhi: The drug major Alkem Health Sciences has got the go-ahead from the Subject Expert Committee (SEC) functional under ...
New Delhi: In line with the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under Central Drug Standard ...
New Delhi: Pharmaceutical major, AstraZeneca has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard ...
The Medical Device Alert stated that HOYA Surgical Optics is recalling HOYA Vivinex iSert Toric IOLs from a specified manufacturing ...
This came after the firm presented their justification for the conduct of clinical trial Phase IIIb where the primary objective ...
This came after the firm presented a bioequivalence (BE) study report and Phase III clinical trial study of the FDC ...
At the SEC meeting for Oncology & Haematology held on 11th of May 2023, the expert panel reviewed the proposal ...
© Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical News Hubb All rights reserved.